article thumbnail

ARS Pharmaceuticals Snags $55M In Series D Funding

socalTECH

San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to better treat severe allergic reaction, said today that it has raised $55M in a Series D funding. The funding was led by SR One, and also included RA Capital Management, an un-named US healthcare-focused fund, and Deerfield Management.

Funding 113
article thumbnail

Memorang Gets $500K For Flash Card Study Tool

socalTECH

Los Angeles-based Memorang , the developer of a flash-card based, study tool to help people study for such things as the MCAT, GRE, NBME, and a host of other tests, has raised $500,000 in a funding round, the company is announcing this morning. READ MORE>>.

Study 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CARI Health Connects With $2.3M

socalTECH

in a seed funding round. The funding came from the San Diego Angel Conference, NuFund Venture Group, Cove Fund, Chemical Angel Fund, Medical Devices of Tomorrow, along with other individual investors. The company said the funding will go towards in-patient clinical studies.

San Diego 133
article thumbnail

Axonics Ups Series C Funding By $20.5M

socalTECH

more in its Series C funding, bringing the funding in the round to a total of $35M. The funding also included Cormorant Asset Management. As part of the funding, Gilde Healthcare's Geoff Pardo joins the company's board. Irvine-based medical device maker Axonics Modulation Technologies has raised $20.5M

Funding 133
article thumbnail

ONK Therapeutics Snags $21.5M for NK Cell Therapies

socalTECH

in its Series A funding. The funding was led by Acorn Bioventures and ALSHC, plus Cormorant Asset Management. ONK said the new funding will go to drive multiple, pre-clinical programs through IND-enabling studies, and also go towards GMP manufacturing capability. The company's CEO is Chris Nowers.

San Diego 200
article thumbnail

Epic Sciences Raises $40M In Series D Funding

socalTECH

San Diego-based Epic Sciences has raised $40M in a Series D funding, for its cancer testing technology, the company announced Friday morning. The company said the fund will go to accelerate clinical studies and enhance its technology. The company has now raised $85.5M READ MORE>>.

Funding 153
article thumbnail

Interview With Jamie Montgomery, March Capital Partners On The Firm's New Fund

socalTECH

Santa Monica-based venture investor March Capital Partners (www.marchcp.com) announced last week that it has raised a second fund, worth $300M. To learn about the new fund, we sat down with Jamie Montgomery , one of the fund's co-founders, to hear about March Capital's strategy and the new fund.

Funding 160